Dynamic contrast-enhanced magnetic resonance imaging:: A useful tool for characterizing ovarian epithelial tumors

被引:116
作者
Thomassin-Naggara, Isabelle [1 ,4 ]
Darai, Emile [2 ]
Cuenod, Charles A. [4 ,5 ]
Rouzier, Roman [2 ]
Callard, Patrice [3 ]
Bazot, Marc [1 ]
机构
[1] Hop Tenon, AP HP, Serv Radiol, F-75020 Paris, France
[2] Hop Tenon, AP HP, Serv Gynecol Obstet, F-75020 Paris, France
[3] Hop Tenon, AP HP, Serv Anatomopathol, F-75020 Paris, France
[4] Univ Paris 05, AP HP, LRI EA4062, Paris, France
[5] HEGP, AP HP, Serv Radiol, Paris, France
关键词
ovarian tumors; magnetic resonance imaging; dynamic contrast-enhanced imaging perfusion; functional imaging;
D O I
10.1002/jmri.21377
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Purpose: To evaluate the utility of dynamic contrast enhancement (DCE) MRI for distinguishing among benign, borderline and invasive epithelial ovarian tumors. Materials and Methods: We analyzed preoperative MRI studies of 37 patients with ovarian epithelial tumors (10 benign, 11 borderline, and 16 invasive). A DCE-MRI sequence was acquired and regions of interest (ROIs) were drawn in the ovarian tumors and adjacent myometrium. A total of three patterns of enhancement were defined. Dynamic data were parameterized using mathematical models that included the enhancement amplitude (EA), the time of half rising (THR), and the maximal slope (MS). Using myometrium as the internal reference, ratios of EA (EAr), THR (THRr), MS (MSr), and initial area under the curve for 60 seconds after injection (IAUC(60) ratio) were determined. Results: Morphological criteria such as septa, papillary projection, solid portion, and T2-weighted MR signal intensity of solid tissue were useful for discriminating invasive from noninvasive ovarian tumors (P = 0.01, P = 0.02, P = 0.002, and P < 0.0001 respectively) but not for discriminating benign from borderline tumors. Curve type 3 was specific for invasive ovarian tumors. EAr, MSr, and IAUC(60) ratio were higher for invasive than for benign (P < 0.0001) and borderline tumors (P = 0.005, P = 0.002, and P = 0.001, respectively). The IAU(60) ratio was the most relevant factor for discriminating benign from borderline and invasive tumors. MSr and IAU(60) ratio could be combined to generate, a decision tree with 81% accuracy. Conclusion: DCE-MRI is a useful tool for characterizing epithelial ovarian tumors.
引用
收藏
页码:111 / 120
页数:10
相关论文
共 33 条
[1]   MR imaging compared with intraoperative frozen-section examination for the diagnosis of adnexal tumors; correlation with final histology [J].
Bazot, Marc ;
Nassar-Slaba, Jinane ;
Thomassin-Naggara, Isabelle ;
Cortez, Annie ;
Uzan, Serge ;
Darai, Emile .
EUROPEAN RADIOLOGY, 2006, 16 (12) :2687-2699
[2]   EPITHELIAL TUMORS OF THE OVARY - CT FINDINGS AND CORRELATION WITH US [J].
BUY, JN ;
GHOSSAIN, MA ;
SCIOT, C ;
BAZOT, M ;
GUINET, C ;
PREVOT, S ;
HUGOL, D ;
LAROMIGUIERE, M ;
TRUC, JB ;
POITOUT, P ;
VADROT, D ;
ECOIFFIER, J .
RADIOLOGY, 1991, 178 (03) :811-818
[3]   Laparoscopic management of organic ovarian cysts: is there a place for frozen section diagnosis? [J].
Chapron, C ;
Dubuisson, JB ;
Kadoch, O ;
Capella-Allouc, S ;
Vacher-Lavenu, MC .
HUMAN REPRODUCTION, 1998, 13 (02) :324-329
[4]   MANAGEMENT OF THE ADNEXAL MASS [J].
CURTIN, JP .
GYNECOLOGIC ONCOLOGY, 1994, 55 (03) :S42-S46
[5]   Laparoscopic restaging of borderline ovarian tumors [J].
Darai, E. ;
Tulpin, L. ;
Prugnolle, H. ;
Cortez, A. ;
Dubernard, G. .
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES, 2007, 21 (11) :2039-2043
[6]  
Evelhoch JL, 1999, JMRI-J MAGN RESON IM, V10, P254, DOI 10.1002/(SICI)1522-2586(199909)10:3<254::AID-JMRI5>3.0.CO
[7]  
2-9
[8]   Laparoscopic management of borderline ovarian tumors:: results of a French multicenter study [J].
Fauvet, R ;
Boccara, J ;
Dufournet, C ;
Poncelet, C ;
Daraï, E .
ANNALS OF ONCOLOGY, 2005, 16 (03) :403-410
[9]   Restaging surgery for women with borderline ovarian tumors -: Results of a French multicenter study [J].
Fauvet, R ;
Boccara, J ;
Dufournet, C ;
David-Montefiore, E ;
Poncelet, C ;
Daraï, E .
CANCER, 2004, 100 (06) :1145-1151
[10]  
HART WR, 1973, CANCER, V31, P1031, DOI 10.1002/1097-0142(197305)31:5<1031::AID-CNCR2820310501>3.0.CO